Matches in Wikidata for { <http://www.wikidata.org/entity/Q80167403> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q80167403 description "article scientifique publié en 2006" @default.
- Q80167403 description "artículu científicu espublizáu en setiembre de 2006" @default.
- Q80167403 description "scientific article published on 01 September 2006" @default.
- Q80167403 description "wetenschappelijk artikel" @default.
- Q80167403 description "наукова стаття, опублікована у вересні 2006" @default.
- Q80167403 name "OASIS-5: how do fondaparinux and enoxaparin compare in patients with acute coronary syndromes?" @default.
- Q80167403 name "OASIS-5: how do fondaparinux and enoxaparin compare in patients with acute coronary syndromes?" @default.
- Q80167403 type Item @default.
- Q80167403 label "OASIS-5: how do fondaparinux and enoxaparin compare in patients with acute coronary syndromes?" @default.
- Q80167403 label "OASIS-5: how do fondaparinux and enoxaparin compare in patients with acute coronary syndromes?" @default.
- Q80167403 prefLabel "OASIS-5: how do fondaparinux and enoxaparin compare in patients with acute coronary syndromes?" @default.
- Q80167403 prefLabel "OASIS-5: how do fondaparinux and enoxaparin compare in patients with acute coronary syndromes?" @default.
- Q80167403 P1433 Q80167403-1F8D7CB3-D3CA-4DDC-A49C-D45810E693FA @default.
- Q80167403 P1476 Q80167403-F6608B47-1115-45C4-AA88-A4CE60365F38 @default.
- Q80167403 P2093 Q80167403-24B69E88-8F74-4FE4-BEDA-CBCEC982498F @default.
- Q80167403 P2093 Q80167403-41731E6F-FDBC-470E-89D2-3ADB26D45486 @default.
- Q80167403 P2860 Q80167403-3F4FA7CD-96FD-48CE-A1BC-B9F0F83F9C54 @default.
- Q80167403 P2860 Q80167403-43B98ED9-179C-458C-9555-C283A02CFACA @default.
- Q80167403 P2860 Q80167403-4F8810B6-0586-4C20-BBE9-59623834CE36 @default.
- Q80167403 P2860 Q80167403-E3079BC5-F61B-457F-9364-A9EC256333DD @default.
- Q80167403 P304 Q80167403-962EAD17-0564-48B6-8DDF-05515A73FD2B @default.
- Q80167403 P31 Q80167403-1FCEAC5A-53BE-4695-9F6A-39832CC3AF29 @default.
- Q80167403 P356 Q80167403-F64FD8B7-1E4C-4FBC-BBBA-273F2282C676 @default.
- Q80167403 P433 Q80167403-C71329EA-2B5A-4F52-AA72-05AF3BF86BD9 @default.
- Q80167403 P478 Q80167403-2D59C3DD-2F03-43E5-9627-576B5DACCB04 @default.
- Q80167403 P577 Q80167403-24D60D3B-E024-4A8C-BCDA-142D820AFF77 @default.
- Q80167403 P698 Q80167403-E51B3491-9A0D-4150-96E9-35CBCA834140 @default.
- Q80167403 P356 NCPCARDIO0639 @default.
- Q80167403 P698 16932761 @default.
- Q80167403 P1433 Q15727036 @default.
- Q80167403 P1476 "OASIS-5: how do fondaparinux and enoxaparin compare in patients with acute coronary syndromes?" @default.
- Q80167403 P2093 "Gary M Idelchik" @default.
- Q80167403 P2093 "James J Ferguson" @default.
- Q80167403 P2860 Q28188101 @default.
- Q80167403 P2860 Q32067182 @default.
- Q80167403 P2860 Q34326602 @default.
- Q80167403 P2860 Q38408470 @default.
- Q80167403 P304 "474-475" @default.
- Q80167403 P31 Q13442814 @default.
- Q80167403 P356 "10.1038/NCPCARDIO0639" @default.
- Q80167403 P433 "9" @default.
- Q80167403 P478 "3" @default.
- Q80167403 P577 "2006-09-01T00:00:00Z" @default.
- Q80167403 P698 "16932761" @default.